Synapse - Chau Dang

Results (273)

Bevacizumab (Bv) in the adjuvant treatment of HER2-negative breast cancer: Final results from Eastern Cooperative Oncology Group E5103

Meeting Abstract

Miller, K.; O'Neill, A. M.; Dang, C. T.; Northfelt, D. W.; Gradishar, W. J.; Goldstein, L. J.; Mayer, I. A.; Brufsky, A.; Bloom, S. H.; Sparano, J. A.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Phase II feasibility study of paclitaxel (T) with trastuzumab (H) and lapatinib (L) for node-negative, HER2-positive breast cancer (BC)

Meeting Abstract

Iyengar, N. M.; Fornier, M. N.; Sugarman, S.; Theodoulou, M.; Troso-Sandoval, T. A.; D'Andrea, G.; Drullinsky, P.; Fasano, J.; Gajria, D.; Goldfarb, S. B.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Gene expression signatures in pre- and post-therapy (Rx) specimens from CALGB 40601 (Alliance), a neoadjuvant phase III trial of weekly paclitaxel and trastuzumab with or without lapatinib for HER2-positive breast cancer (BrCa)

Meeting Abstract

Carey, L. A.; Barry, W. T.; Pitcher, B.; Hoadley, K. A.; Cheang, M. C. U.; Anders, C. K.; Henry, N. L.; Tolaney, S. M.; Dang, C. T.; Krop, I. E.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

A virtual consult service to optimize clinical trial participation in patients with metastatic breast cancer

Meeting Abstract

Cadoo, K. A.; Shah, P. D.; Charen, A. S.; Bromberg, J.; Comen, E. A.; D'Andrea, G.; Dang, C. T.; Gilewski, T.; Gucalp, A.; Lake, D.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100

Journal Article

Schneider, B. P.; Li, L.; Shen, F.; Miller, K. D.; Radovich, M.; O'neill, A.; Gray, R. J.; Lane, D.; Flockhart, D. A.; Jiang, G.; more...
British Journal of Cancer (2014)

Fulltext@MSK | Save

Breast cancer

Book Section

Iyengar, N. M.; Dang, C. T.; Morikawa, A.; Seidman, A. D.
In Drilon, A. E.; Postow, M. A.; Krug, L. M. (Eds.) Pocket Oncology (2014)

Fulltext@MSK | Save

Biomarker prediction of chemotherapy-related amenorrhea in premenopausal women with breast cancer participating in E5103

Journal Article

Ruddy, K. J.; O'neill, A.; Miller, K. D.; Schneider, B. P.; Baker, E.; Sparano, J. A.; Dang, C.; Northfelt, D. W.; Sledge, G. W. Jr; Partridge, A. H.
Breast Cancer Research and Treatment (2014)

Fulltext@MSK | Save

Biomarker prediction of chemotherapy-related amenorrhea

Meeting Abstract

Ruddy, K. J.; O'Neill, A. M.; Miller, K.; Schneider, B. P.; Baker, E.; Sparano, J. A.; Dang, C. T.; Northfelt, D. W.; Sledge, G. W.
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Does biomarker information impact patients' preferences for therapy?

Meeting Abstract

Partridge, A. H.; Sepucha, K.; O'Neill, A.; Miller, K.; Baker, E.; Dang, C. T.; Northfelt, D. W.; Sledge, G. W.; Schneider, B. P.
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Longer-term cardiac safety and outcomes of dose dense (dd) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) and trastuzumab (H) with and without lapatinib (L) in patients (pts) with early breast cancer (BC)

Meeting Abstract

Morris, P. G.; Iyengar, N. M.; Patil, S.; Chen, C.; Abbruzzi, A.; Lehman, R. J.; Steingart, R.; Oeffinger, K. C.; Lin, N.; Moy, B.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save